M. Anne Fahrni, PhD

Senior Patent Agent

Send email

Dr. M. Anne Fahrni earned her M.S. and Ph.D. in organic chemistry from Northwestern University under the tutelage of LyricaÒ inventor Professor Richard B. Silverman, in the area of neurological disease. Anne then began her professional career working in research and development of regenerative medicine, treatments for cancer and obesity, as well as working at the Centers for Disease Control and Prevention in Atlanta, where she conducted research involving virus proteomics.

In 2004, Anne expanded her career to include patent application preparation and prosecution first as a scientific advisor. She was then registered to practice before the U.S. Patent and Trademark Office in 2005 and worked as a patent agent at law firms in the Atlanta area for several years. Anne joined Wood IP as a senior patent agent in 2016.

Anne has experience in patent preparation and prosecution and portfolio management in a wide range of technical areas,  including chemical, biotechnology, pharmaceuticals, material science, medical devices, information technology, and mechanical arts. Her work also includes patentability opinions and conducting freedom-to-operate and infringement analysis and other IP-related due diligence.

Anne has been active with a number of professional organizations such as National Association of Patent Practitioners (NAPP), Georgia IP Alliance (GIPA), Women in Bio (WIB), and Chiefs in Intellectual Property (ChIPs).

“I am deeply gratified to work with cutting-edge innovation and team up with some of the smartest people in the world.”

    • PhD, Organic Chemistry, Northwestern University
    • M.S., Organic Chemistry, Northwestern University
    • B.S., Physical Chemistry, Lanzhou University
    • U.S. Patent and Trademark Office

    D. Liu, E. Pozharski, M. Fu (Fahrni), R. B. Silverman, D. Ringe, “Mechanism of Inactivation of Escherichia Coli Aspartate Aminotransferase by Inactivation by (S)-4-Amino-4,5-dihydro-2furancarboxylic Acid”, Biochemistry, 2010, 49, 10507-10515.

    B.W. Lepore, D. Liu, Y. Peng, M. Fu (Fahrni), C. Yasuda, J. Manning, R. B. Silverman, D. Ringe, “Chiral Discrimination among Aminotransferases: Inactivation by 4-Amino-4,5-dihydro thiophenecarboxylic Acid”, Biochemistry, 2010, 49, 3138-3147.

    D. Liu, E. Pozharski, B. Lepore, M. Fu (Fahrni), R. B. Silverman, G. A. Petsko, D. Ringe, “Inactivation of Escherichia coli L-aspartate aminotransferase by (S)-4-Amino-4,5-dihydro-2thiophenecarboxylic acid reveals “A tale of two mechanisms”, Biochemistry 200746, 10517.

    M. Fu (Fahrni), R. B. Silverman, “Inactivation of γ-Aminobutyric Acid Aminotransferase by (S)-4Amino-4,5-dihydro-2-furancarboxylic Acid Does Not Proceed by the Expected Aromatization Mechanism”, Bioorg. Med. Chem. Lett., 2004, 14, 203-206.

    P. C. Kearney, M. Fernandez, M. Fu (Fahrni), J. A. Flygare, “Solid-Phase Synthesis of 2-Aminothiazoles”, Solid-Phase Organic Syntheses, Wiley: San Diego, 2001, p. 1.

    M. Fu (Fahrni), M. Fernandez, J. A. Flygare, “Traceless Solid-Phase Synthesis of 2Aminoimidazolone Libraries”, Org. Lett19991, 1351.

    M. Fu (Fahrni), D. Nikolic, R. B. Van Breemen, R. B. Silverman, “Mechanism of Inactivation of γAminobutyric Acid Aminotransferase by (S)-4-Amino-4,5-dihydro-2-thiophenecarboxylic Acid”, J. Am. Chem. Soc., 1999121, 7751.

    M. Fu (Fahrni), R. B. Silverman, “Isolation and Characterization of the Product of Inactivation of γAminobutyric Acid Aminotransferase by Gabaculine”, Bioorg. Med. Chem., 19997, 1581.

    G. T. Olson, M. Fu (Fahrni), S. Lau, K. L. Rinehart, R. B. Silverman, “An Aromatization Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase for the Antibiotic L-Cycloserine”, J. Am. Chem. Soc., 1998120, 2256.